$KSEZ
Kinetic Seas Inc.

2023 Q1 Form 10-K Financial Statement

#000168316823001957 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $2.726K $75.65K
YoY Change 101.93% 110.73%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $2.726K $75.65K
YoY Change 101.93% 110.73%
Operating Profit -$2.726K -$75.65K
YoY Change 101.93% 110.73%
Interest Expense $4.596K $18.48K
YoY Change 104.45% 1226.49%
% of Operating Profit
Other Income/Expense, Net -$4.596K -$18.48K
YoY Change 104.45% -131.53%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$7.322K -$94.13K
YoY Change 103.5% -514.58%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 140.8M shares 140.8M shares 140.8M shares
Diluted Shares Outstanding 140.8M shares 140.8M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $13.36K $1.376K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.36K $1.376K
YoY Change -70.49%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $13.36K $1.376K
Total Long-Term Assets $0.00 $0.00
Total Assets $13.36K $1.376K
YoY Change -70.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.07K $12.37K
YoY Change
Accrued Expenses $33.49K $33.49K
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $176.8K $157.5K
YoY Change 136.24%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $176.8K $157.5K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$964.2K -$956.8K
YoY Change 10.91%
Common Stock $1.408K $1.408K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$163.5K -$156.1K
YoY Change
Total Liabilities & Shareholders Equity $13.36K $1.376K
YoY Change -70.49%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$7.322K -$94.13K
YoY Change 103.5% -514.58%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$4.021K -$63.29K
YoY Change 114.71%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $16.00K $60.00K
YoY Change -20.0% 87.5%
NET CHANGE
Cash From Operating Activities -$4.021K -$63.29K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $16.00K $60.00K
Net Change In Cash $11.98K -$3.287K
YoY Change -40.11% -230.23%
FREE CASH FLOW
Cash From Operating Activities -$4.021K -$63.29K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$4.021K -$63.29K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
140790867 shares
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001945619
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56478
CY2022 dei Entity Registrant Name
EntityRegistrantName
BELLATORA, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1981170
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2030 Powers Ferry Rd SE
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite #212
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
CY2022 dei City Area Code
CityAreaCode
404
CY2022 dei Local Phone Number
LocalPhoneNumber
816 -8240
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q4 us-gaap Cash
Cash
1376 usd
CY2021Q4 us-gaap Cash
Cash
4663 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1376 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4663 usd
CY2022Q4 us-gaap Assets
Assets
1376 usd
CY2021Q4 us-gaap Assets
Assets
4663 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12366 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
21674 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3196 usd
CY2022Q4 ECGR Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
90000 usd
CY2021Q4 ECGR Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
30000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
157526 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
66681 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140790867 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140790867 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140790867 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140790867 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1408 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1408 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
799278 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
799278 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-956835 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-862704 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-156149 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-62018 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1376 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4663 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Gross Profit
GrossProfit
0 usd
CY2021 us-gaap Gross Profit
GrossProfit
0 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75653 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35901 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
75653 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
35901 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-75653 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-35901 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
60000 usd
CY2022 us-gaap Interest Expense
InterestExpense
18478 usd
CY2021 us-gaap Interest Expense
InterestExpense
1393 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18478 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
58607 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-94131 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22705 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140790867 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140790867 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140790867 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140790867 shares
CY2020Q4 us-gaap Shares Outstanding
SharesOutstanding
40790867 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-105724 usd
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000000 shares
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22705 usd
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
140790867 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-62018 usd
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
140790867 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-62018 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-94131 usd
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
140790867 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-156149 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-94131 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22705 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
60000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12366 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17750 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
18478 usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3195 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3373 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63287 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29476 usd
CY2022 ECGR Common Stock Issued For Cash Cash Flow
CommonStockIssuedForCashCashFlow
0 usd
CY2021 ECGR Common Stock Issued For Cash Cash Flow
CommonStockIssuedForCashCashFlow
1000 usd
CY2022 ECGR Warrants Issued For Cash Cash Flow
WarrantsIssuedForCashCashFlow
0 usd
CY2021 ECGR Warrants Issued For Cash Cash Flow
WarrantsIssuedForCashCashFlow
1000 usd
CY2022 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
60000 usd
CY2021 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
30000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10556 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
10556 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3287 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2525 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4663 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2139 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1376 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4663 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zgD0tFmFWRx2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86A_z7FpdfT9iZ7f">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of accrued liabilities and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition, valuation of accounts receivable and the allowance for doubtful accounts, inventories, and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1376 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4663 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-956835 usd
CY2022Q4 ECGR Working Capital
WorkingCapital
-156150 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140790867 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
140790867 shares

Files In Submission

Name View Source Status
0001683168-23-001957-index-headers.html Edgar Link pending
0001683168-23-001957-index.html Edgar Link pending
0001683168-23-001957.txt Edgar Link pending
0001683168-23-001957-xbrl.zip Edgar Link pending
bellatora_ex3101.htm Edgar Link pending
bellatora_ex3201.htm Edgar Link pending
bellatora_i10k-123122.htm Edgar Link pending
ecgr-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
ecgr-20221231_def.xml Edgar Link unprocessable
ecgr-20221231_cal.xml Edgar Link unprocessable
ecgr-20221231_lab.xml Edgar Link unprocessable
ecgr-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bellatora_i10k-123122_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending